Thrivent International Equity Class S (TWAIX) is a Foreign Large Blend fund with $978.20 Million in assets. The fund allocates 20.01% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Thrivent Core Short-Term Reserve Fund at 6.80% of total assets. This is followed by Novartis AG (1.75%) and Shell plc (1.56%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Thrivent Core Short-Term Reserve Fund | 6.80% | - | - |
| Novartis AG | 1.75% | - | - |
| Shell plc | 1.56% | - | - |
| ASML Holding NV | 1.55% | - | - |
| AstraZeneca plc | 1.50% | - | - |
| Novo Nordisk AS | 1.68% | - | - |
| Allianz SE | 1.40% | - | - |
| ABB, Ltd. | 1.36% | - | - |
| Alimentation Couche-Tard, Inc. | 1.27% | - | - |
| Canadian National Railway Company | 1.14% | - | - |
| U.S. Treasury Bills | 1.72% | - | - |
| Roche Holding AG, Participation Certificates | 1.20% | - | - |
| Givaudan SA | 1.38% | - | - |
| Federal Home Loan Bank Discount Notes | 1.28% | - | - |
| State Street Institutional U.S. Government Money Market Fund | 2.79% | - | - |
| Taiwan Semiconductor Manufacturing Company, Ltd. | 1.20% | - | - |
| Safran SA | 1.20% | - | - |